🧪 Ready, set, degrade!
So proud to share our work in the
@jclinical-invest.bsky.social, establishing a versatile approach for creating transgenic dTAG mice to degrade oncoproteins. We showcase that KRAS G12V degradation triggers antitumor immunity in lung cancer.
Link:
www.jci.org/articles/vie...